Acrux Limited (ARUXF)
ARUXF Stock Price Chart
Explore Acrux Limited interactive price chart. Choose custom timeframes to analyze ARUXF price movements and trends.
ARUXF Company Profile
Discover essential business fundamentals and corporate details for Acrux Limited (ARUXF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
8 Jun 2010
Employees
—
Website
https://www.acrux.com.auCEO
Michael John Kotsanis BSc, GradDipBus, MBus
Description
Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. The company was incorporated in 1998 and is based in West Melbourne, Australia.
ARUXF Financial Timeline
Browse a chronological timeline of Acrux Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 23 Feb 2026
Earnings released on 21 Aug 2025
Earnings released on 30 Apr 2025
EPS came in at -$0.01 , while revenue for the quarter reached $1.06M .
Earnings released on 30 Oct 2024
EPS came in at -$0.01 , while revenue for the quarter reached $454.73K .
Earnings released on 30 Apr 2024
EPS came in at -$0.01 , while revenue for the quarter reached $3.00M .
Earnings released on 30 Jun 2023
EPS came in at $0.01 , while revenue for the quarter reached $4.65M .
Earnings released on 31 Dec 2022
EPS came in at -$0.01 , while revenue for the quarter reached $971.10K .
Earnings released on 30 Jun 2022
EPS came in at -$0.01 , while revenue for the quarter reached $699.26K .
Earnings released on 31 Dec 2021
EPS came in at -$0.01 , while revenue for the quarter reached $508.83K .
Earnings released on 30 Jun 2021
EPS came in at -$0.01 , while revenue for the quarter reached $412.18K .
Earnings released on 31 Dec 2020
EPS came in at -$0.03 , while revenue for the quarter reached $604.31K .
ARUXF Stock Performance
Access detailed ARUXF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.